홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
RVPH
#3760
Reviva Pharmaceuticals Holdings, Inc. Common Stock
0.2
1
-4.55%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-4.55%
월간 변동
-32.26%
6달 변화
-55.32%
년간 변동율
-85.00%
이전 종가
0.2
2
Open
0.2
1
Bid
Ask
Low
0.2
1
High
0.2
1
양
6
마켓
주식
헬스케어
RVPH
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
33.44 M
46.74 M
46.74 M
68 M
115.06 M
—
Valuation ratios
Enterprise value
42.6 M
71.12 M
39.29 M
15.55 M
29.23 M
155.19 M
Price to earnings ratio
0.69
-2.01
-1.16
-0.55
-0.74
-4.45
Price to sales ratio
53.81
83.6
99.19
116.02
483.19
781.99
Price to cash flow ratio
-1.23
-1.79
-1.13
-0.57
-0.59
-4.08
Price to book ratio
-4.84
73.84
-1.7
-1.03
-26.73
44.38
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-1.1
-0.4
-0.91
-0.52
-0.28
-2.11
Return on equity %
0.84
-7.7
1.44
13.18
-0.88
6.04
Return on invested capital %
-407.97
-309.31
-359.29
-375.04
-318.98
-1 362.62
Gross margin %
100
100
100
100
100
400
Operating margin %
-11.7 K
56.49 K
-10.68 K
-54.58 K
14.49 K
5 705.23
EBITDA margin %
—
—
—
—
—
—
Net margin %
-11.57 K
56.26 K
-10.51 K
-54.41 K
14.42 K
5 757.06
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
0.39
1.01
0.54
0.9
1.39
3.83
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
-0
0.01
0
-0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.13
-0.27
-0.17
-0.1
-0.08
-0.62
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.16
0.41
0.11
0.21
0.18
0.9
Net current asset value per share
0.2
0.44
0.13
0.22
0.19
0.97
Tangible book value per share
-0.3
0.02
-0.09
-0.01
0.06
-0.01
Working capital per share
-0.32
0
-0.11
-0.03
0.05
-0.08
Book value per share
-0.3
0.02
-0.09
-0.01
0.06
-0.01
뉴스
브릴라록사진, 음성 바이오마커 연구에서 정신분열증 효능 입증
Vocal biomarker study supports brilaroxazine’s efficacy in schizophrenia
차단 캐피털, 레비바 파마슈티컬 주식에 ’매수’ 등급 제시
Chardan Capital assumes coverage on Reviva Pharmaceuticals stock with Buy rating
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/30/25 - TipRanks.com
Reviva Pharmaceuticals, H.C. Wainwright ’매수’ 등급 재확인
Reviva Pharmaceuticals stock rating reiterated at Buy by H.C. Wainwright
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.16%
레비바 제약, FDA의 2상 임상 재요청에 주가 급락
Reviva Pharmaceuticals stock plunges after FDA requests second Phase 3 trial
FDA, 레비바 정신분열증 치료제 2상 임상 권고
FDA recommends second phase 3 trial for Reviva’s schizophrenia drug